Envelope glycoproteins of Human Immunodeficiency Virus type 1 variants issued from mother-infant pairs display a wide spectrum of biological properties

Virology

Volumn 426, Issue 1, 2012, Pages 12-21

  Thenin, Suzie ^a   Samleerat, Tanawan ^b   Tavernier, Elsa ^c,e   Ngo Giang Huong, Nicole ^d   Jourdain, Gonzague ^d   Lallemant, Marc ^d   Barin, Francis ^a   Braibant, Martine ^a  

^a UNIVERSITÉ DE TOURS   (France)

^b CHIANG MAI UNIVERSITY   (Thailand)

^c INSERM   (France)

^d Institute of research for development Thailand   (Thailand)

^e UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

Biological properties; CFR01_AE clade; Env pseudotyped viruses; HIV 1; Mother to child transmission; Neutralization

Indexed keywords

GLYCOPROTEIN GP 120; PROTEIN VARIANT;

ANTIGENICITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; VERTICAL TRANSMISSION; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION; VIRUS TRANSMISSION;

ADULT; CELL LINE; FEMALE; GENETIC VARIATION; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PHYLOGENY;

AVIAN ENCEPHALOMYELITIS VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84857685199     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.01.017     Document Type: Article

References (48)

1. Ahmad N., Baroudy B.M., Baker R.C., Chappey C. Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. J. Virol. 1995, 69(2):1001-1012.
2. Barin F., Jourdain G., Brunet S., Ngo-Giang-Huong N., Weerawatgoompa S., Karnchanamayul W., Ariyadej S., Hansudewechakul R., Achalapong J., Yuthavisuthi P., Ngampiyaskul C., Bhakeecheep S., Hemwutthiphan C., Lallemant M. Revisiting the role of neutralizing antibodies in mother-to-child transmission of HIV-1. J. Infect. Dis. 2006, 193(11):1504-1511.
3. Binley J.M., Ban Y.E., Crooks E.T., Eggink D., Osawa K., Schief W.R., Sanders R.W. Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization. J. Virol. 2010, 84(11):5637-5655.
4. Bongertz V., Costa C.I., Veloso V.G., Grinsztejn B., Filho E.C., Calvet G., Pilotto J.H. Neutralization titres and vertical HIV-1 transmission. Scand. J. Immunol. 2002, 56(6):642-644.
5. Braibant M., Xie J., Samri A., Agut H., Autran B., Barin F. Disease progression due to dual infection in an HLA-B57-positive asymptomatic long-term nonprogressor infected with a nef-defective HIV-1 strain. Virology 2010, 405(1):81-92.
6. Burton D.R., Pyati J., Koduri R., Sharp S.J., Thornton G.B., Parren P.W., Sawyer L.S., Hendry R.M., Dunlop N., Nara P.L., et al. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 1994, 266(5187):1024-1027.
7. Chohan B., Lang D., Sagar M., Korber B., Lavreys L., Richardson B., Overbaugh J. Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels. J. Virol. 2005, 79(10):6528-6531.
8. Connor R.I., Chen B.K., Choe S., Landau N.R. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995, 206(2):935-944.
9. Crooks E.T., Moore P.L., Franti M., Cayanan C.S., Zhu P., Jiang P., de Vries R.P., Wiley C., Zharkikh I., Schulke N., Roux K.H., Montefiori D.C., Burton D.R., Binley J.M. A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120. Virology 2007, 366(2):245-262.
10. Derdeyn C.A., Decker J.M., Bibollet-Ruche F., Mokili J.L., Muldoon M., Denham S.A., Heil M.L., Kasolo F., Musonda R., Hahn B.H., Shaw G.M., Korber B.T., Allen S., Hunter E. Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 2004, 303(5666):2019-2022.
11. Dickover R.E., Garratty E.M., Plaeger S., Bryson Y.J. Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum. J. Virol. 2001, 75(5):2194-2203.
12. Dickover R., Garratty E., Yusim K., Miller C., Korber B., Bryson Y. Role of maternal autologous neutralizing antibody in selective perinatal transmission of human immunodeficiency virus type 1 escape variants. J. Virol. 2006, 80(13):6525-6533.
13. Englund J., Glezen W.P., Piedra P.A. Maternal immunization against viral disease. Vaccine 1998, 16(14-15):1456-1463.
14. Frost S.D., Liu Y., Pond S.L., Chappey C., Wrin T., Petropoulos C.J., Little S.J., Richman D.D. Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B. J. Virol. 2005, 79(10):6523-6527.
15. Guevara H., Casseb J., Zijenah L.S., Mbizvo M., Oceguera L.F., Hanson C.V., Katzenstein D.A., Hendry R.M. Maternal HIV-1 antibody and vertical transmission in subtype C virus infection. J. Acquir. Immune Defic. Syndr. 2002, 29(5):435-440.
16. Haim H., Si Z., Madani N., Wang L., Courter J.R., Princiotto A., Kassa A., DeGrace M., McGee-Estrada K., Mefford M., Gabuzda D., Smith A.B., Sodroski J. Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated state. PLoS Pathog. 2009, 5(4):e1000360.
17. Hengel R.L., Kennedy M.S., Steketee R.W., Thea D.M., Abrams E.J., Lambert G., McDougal J.S. Neutralizing antibody and perinatal transmission of human immunodeficiency virus type 1. New York City Perinatal HIV Transmission Collaborative Study Group. AIDS Res. Hum. Retroviruses 1998, 14(6):475-481.
18. Husson R.N., Lan Y., Kojima E., Venzon D., Mitsuya H., McIntosh K. Vertical transmission of human immunodeficiency virus type 1: autologous neutralizing antibody, virus load, and virus phenotype. J. Pediatr. 1995, 126(6):865-871.
19. Kishko M., Somasundaran M., Brewster F., Sullivan J.L., Clapham P.R., Luzuriaga K. Genotypic and functional properties of early infant HIV-1 envelopes. Retrovirology 2011, 8(1):67.
20. Koch M., Pancera M., Kwong P.D., Kolchinsky P., Grundner C., Wang L., Hendrickson W.A., Sodroski J., Wyatt R. Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition. Virology 2003, 313(2):387-400.
21. Kong X., West J.T., Zhang H., Shea D.M., M'Soka T.J., Wood C. The human immunodeficiency virus type 1 envelope confers higher rates of replicative fitness to perinatally transmitted viruses than to nontransmitted viruses. J. Virol. 2008, 82(23):11609-11618.
22. Lallemant M., Jourdain G., Le Coeur S., Kim S., Koetsawang S., Comeau A.M., Phoolcharoen W., Essex M., McIntosh K., Vithayasai V. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N. Engl. J. Med. 2000, 343(14):982-991.
23. Lamers S.L., Sleasman J.W., She J.X., Barrie K.A., Pomeroy S.M., Barrett D.J., Goodenow M.M. Persistence of multiple maternal genotypes of human immunodeficiency virus type I in infants infected by vertical transmission. J. Clin. Invest. 1994, 93(1):380-390.
24. Lathey J.L., Tsou J., Brinker K., Hsia K., Meyer W.A., Spector S.A. Lack of autologous neutralizing antibody to human immunodeficiency virus type 1 (HIV-1) and macrophage tropism are associated with mother-to-infant transmission. J. Infect. Dis. 1999, 180(2):344-350.
25. Lynch J.B., Nduati R., Blish C.A., Richardson B.A., Mabuka J.M., Jalalian-Lechak Z., John-Stewart G., Overbaugh J. The breadth and potency of passively acquired human immunodeficiency virus type 1-specific neutralizing antibodies do not correlate with the risk of infant infection. J. Virol. 2011, 85(11):5252-5261.
26. Malenbaum S.E., Yang D., Cavacini L., Posner M., Robinson J., Cheng-Mayer C. The N-terminal V3 loop glycan modulates the interaction of clade A and B human immunodeficiency virus type 1 envelopes with CD4 and chemokine receptors. J. Virol. 2000, 74(23):11008-11016.
27. Moore J.P., McKeating J.A., Norton W.A., Sattentau Q.J. Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4. J. Virol. 1991, 65(3):1133-1140.
28. Moore P.L., Crooks E.T., Porter L., Zhu P., Cayanan C.S., Grise H., Corcoran P., Zwick M.B., Franti M., Morris L., Roux K.H., Burton D.R., Binley J.M. Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1. J. Virol. 2006, 80(5):2515-2528.
29. Orloff S.L., Kennedy M.S., Belperron A.A., Maddon P.J., McDougal J.S. Two mechanisms of soluble CD4 (sCD4)-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) infectivity and their relation to primary HIV-1 isolates with reduced sensitivity to sCD4. J. Virol. 1993, 67(3):1461-1471.
30. Pancera M., McLellan J.S., Wu X., Zhu J., Changela A., Schmidt S.D., Yang Y., Zhou T., Phogat S., Mascola J.R., Kwong P.D. Crystal structure of PG16 and chimeric dissection with somatically related PG9: structure-function analysis of two quaternary-specific antibodies that effectively neutralize HIV-1. J. Virol. 2010, 84(16):8098-8110.
31. Pasquier C., Cayrou C., Blancher A., Tourne-Petheil C., Berrebi A., Tricoire J., Puel J., Izopet J. Molecular evidence for mother-to-child transmission of multiple variants by analysis of RNA and DNA sequences of human immunodeficiency virus type 1. J. Virol. 1998, 72(11):8493-8501.
32. Platt E.J., Wehrly K., Kuhmann S.E., Chesebro B., Kabat D. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J. Virol. 1998, 72(4):2855-2864.
33. Russell E.S., Kwiek J.J., Keys J., Barton K., Mwapasa V., Montefiori D.C., Meshnick S.R., Swanstrom R. The genetic bottleneck in vertical transmission of subtype C HIV-1 is not driven by selection of especially neutralization-resistant virus from the maternal viral population. J. Virol. 2011, 85(16):8253-8262.
34. Safrit J.T., Ruprecht R., Ferrantelli F., Xu W., Kitabwalla M., Van Rompay K., Marthas M., Haigwood N., Mascola J.R., Luzuriaga K., Jones S.A., Mathieson B.J., Newell M.L. Immunoprophylaxis to prevent mother-to-child transmission of HIV-1. J. Acquir. Immune Defic. Syndr. 2004, 35(2):169-177.
35. Samleerat T., Braibant M., Jourdain G., Moreau A., Ngo-Giang-Huong N., Leechanachai P., Hemvuttiphan J., Hinjiranandana T., Changchit T., Warachit B., Suraseranivong V., Lallemant M., Barin F. Characteristics of HIV type 1 (HIV-1) glycoprotein 120 env sequences in mother-infant pairs infected with HIV-1 subtype CRF01_AE. J. Infect. Dis. 2008, 198(6):868-876.
36. Samleerat T., Thenin S., Jourdain G., Ngo-Giang-Huong N., Moreau A., Leechanachai P., Ithisuknanth J., Pagdi K., Wannarit P., Sangsawang S., Lallemant M., Barin F., Braibant M. Maternal neutralizing antibodies against a CRF01_AE primary isolate are associated with a low rate of intrapartum HIV-1 transmission. Virology 2009, 387(2):388-394.
37. Saphire E.O., Parren P.W., Barbas C.F., Burton D.R., Wilson I.A. Crystallization and preliminary structure determination of an intact human immunoglobulin, b12: an antibody that broadly neutralizes primary isolates of HIV-1. Acta Crystallogr. D Biol. Crystallogr. 2001, 57(Pt 1):168-171.
38. Scarlatti G. Mother-to-child transmission of HIV-1: advances and controversies of the twentieth centuries. AIDS Rev. 2004, 6(2):67-78.
39. Scarlatti G., Albert J., Rossi P., Hodara V., Biraghi P., Muggiasca L., Fenyo E.M. Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates. J. Infect. Dis. 1993, 168(1):207-210.
40. Scarlatti G., Leitner T., Halapi E., Wahlberg J., Marchisio P., Clerici-Schoeller M.A., Wigzell H., Fenyo E.M., Albert J., Uhlen M., et al. Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers. Proc. Natl. Acad. Sci. U. S. A. 1993, 90(5):1721-1725.
41. Utachee P., Jinnopat P., Isarangkura-Na-Ayuthaya P., de Silva U.C., Nakamura S., Siripanyaphinyo U., Wichukchinda N., Tokunaga K., Yasunaga T., Sawanpanyalert P., Ikuta K., Auwanit W., Kameoka M. Phenotypic studies on recombinant human immunodeficiency virus type 1 (HIV-1) containing CRF01_AE env gene derived from HIV-1-infected patient, residing in central Thailand. Microbes Infect. 2009, 11(3):334-343.
42. Verhofstede C., Demecheleer E., De Cabooter N., Gaillard P., Mwanyumba F., Claeys P., Chohan V., Mandaliya K., Temmerman M., Plum J. Diversity of the human immunodeficiency virus type 1 (HIV-1) env sequence after vertical transmission in mother-child pairs infected with HIV-1 subtype A. J. Virol. 2003, 77(5):3050-3057.
43. Walker L.M., Phogat S.K., Chan-Hui P.Y., Wagner D., Phung P., Goss J.L., Wrin T., Simek M.D., Fling S., Mitcham J.L., Lehrman J.K., Priddy F.H., Olsen O.A., Frey S.M., Hammond P.W., Kaminsky S., Zamb T., Moyle M., Koff W.C., Poignard P., Burton D.R. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 2009, 326(5950):285-289.
44. Wei X., Decker J.M., Liu H., Zhang Z., Arani R.B., Kilby J.M., Saag M.S., Wu X., Shaw G.M., Kappes J.C. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 2002, 46(6):1896-1905.
45. Wolinsky S.M., Wike C.M., Korber B.T., Hutto C., Parks W.P., Rosenblum L.L., Kunstman K.J., Furtado M.R., Munoz J.L. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 1992, 255(5048):1134-1137.
46. Wu X., Parast A.B., Richardson B.A., Nduati R., John-Stewart G., Mbori-Ngacha D., Rainwater S.M., Overbaugh J. Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant. J. Virol. 2006, 80(2):835-844.
47. Zhang H., Rola M., West J.T., Tully D.C., Kubis P., He J., Kankasa C., Wood C. Functional properties of the HIV-1 subtype C envelope glycoprotein associated with mother-to-child transmission. Virology 2010, 400(2):164-174.
48. Zhang H., Tully D.C., Hoffmann F.G., He J., Kankasa C., Wood C. Restricted genetic diversity of HIV-1 subtype C envelope glycoprotein from perinatally infected Zambian infants. PLoS One 2010, 5(2):e9294.